FSI «SID & GP»
The Ministry of industry and trade of the Russian Federation
+7 (495) 676-43-60 109044, Moscow, Lavrov lane., 6

Development of the Company’s Portfolio (R&D)

Development of national innovative drugs is one of the focus areas of the Pharma-2030 government programme.

Scientific research is the mainstream component of the modern pharmaceutical industry. Development and manufacturing of innovative drugs give a significant advantage for a pharmaceutical company. A unique, potent, and safe drug is the success factor of a company on the market.

The Industry Analytics Centre offers consultations on the following issues:

  • Market analysis and identifying the promising niche and consumer needs
  • Identification or development of the product that would be in demand with the consumers and beneficial for the company, too.
  • Production cost calculation as per the volume of the product required
  • Consultation on the product launch, competitive environment, benchmark, product launch and promotion strategy.
  • Consultation on the product logistics support.
  • Consultation on management of the product life cycle in the market.